Mouse uterine stem cells are affected by endocrine disruption and initiate uteropathies

Pushpa Singh1, Deepa Bhartiya1

  • 1Stem Cell Biology Department, ICMR-National Institute for Research in Reproductive & Child Health, Parel, Mumbai, India.

Reproduction (Cambridge, England)
|December 9, 2022
PubMed

Insights

Uterine diseases like cancer and endometriosis may stem from dysfunctional very small embryonic-like stem cells (VSELs). Exposure to endocrine disruptors in early development can trigger these stem cell issues, leading to various uteropathies.

Area of Science:

  • Reproductive biology
  • Stem cell research
  • Toxicology

Background:

  • Uteropathies, including cancer, adenomyosis, and endometriosis, are increasing.
  • The precise mechanisms initiating these conditions remain unclear.
  • Tissue-resident stem cells, specifically very small embryonic-like stem cells (VSELs), are implicated.

Purpose of the Study:

  • To investigate the role of VSELs in the development of uteropathies.
  • To explore the impact of early-life exposure to endocrine-disrupting chemicals on uterine stem cells.
  • To identify potential stem cell origins for various uterine diseases.

Main Methods:

  • Mouse pups were exposed to oestradiol or diethylstilbestrol.
  • Adult offspring were analyzed for uterine health, stem cell populations, and gene expression.
  • Flow cytometry and transcript analysis were used to assess VSELs and their differentiation markers.
  • Epigenetic modifications, including DNA methylation and imprinting, were examined.

Main Results:

  • Exposure led to disrupted cycles, reduced uterine weight, and hyperplasia.
  • VSELs increased in number but showed impaired differentiation.
  • Global hypomethylation and oncogenic events were observed.
  • Epigenetic alterations in stem cells, including altered gene imprinting and Ezh2 expression, were noted.

Conclusions:

  • Dysfunction of tissue-resident VSELs is a likely cause of various uteropathies.
  • Early-life exposure to endocrine disruptors can epigenetically alter stem cells, promoting disease.
  • These findings highlight VSELs as a crucial target for understanding and potentially treating uterine diseases.

Related Concept Videos